Pharmaceutical

Home - Products - Pharmaceutical

Cefoperazone sodium

  • Product Name: Cefoperazone sodium
  • CasNo: 62893-20-3
  • Purity:
  • Appearance: Faint beige powder

Mobile/Wechat/WhatsApp: 13666361637

Email:peterkiter@hotmail.com

Inquiry

CasNo: 62893-20-3

Molecular Formula: C25H27N9O8S2. Na

Appearance: Faint beige powder

Top Quality Chinese Factory supply 62893-20-3 Cefoperazone sodium

  • Molecular Formula:C25H27N9O8S2. Na
  • Molecular Weight:667.659
  • Appearance/Colour:Faint beige powder 
  • Melting Point:200-202 °C 
  • PSA:273.69000 
  • LogP:-1.85120 

Cefoperazone sodium(Cas 62893-20-3) Usage

Therapeutic Function

Antibiotic

Biological Activity

cefoperazone is a new semisynthetic cephalosporin with a broad spectrum of antibacterial activity. cefoperazone shows high activity against gram-positive bacteria and gram-negative bacilli, such as escherichia coli, klebsiella pneumoniae, and proteus species [1].

Veterinary Drugs and Treatments

Cefoperazone is used to treat serious infections, particularly susceptible Enterobacteriaceae not susceptible to other less expensive agents or when aminoglycosides are not indicated (due to their potential toxicity).

in vitro

there was only a small spread between the minimum inhibitory concentrations and the minimum bactericidal concentrations of cefoperazone and a significant decrease in activity with an increase in inoculum size. cefoperazone is relatively stable to hydrolysis to β-lactamases produced by gram-negative bacteria. relative rates of hydrolysis of cefoperazone by cephalosporinases were 7.0 to 0.01[1]. in 50 strains of n. gonorrhoeae, the mic50 of cefoperazone was ≤ 0.004-0.06 μg/ml [2].

in vivo

in four patients with cholelithiasis and one patient with carcinoma of the head of the pancreas, all of whom had normal renal functions, cefoperazone was intravenously administrated. in common duct bile, the maximum concentrations of cefoperazone ranged from 373.4 to 3,100 μg/ml while the concentrations ranged from 6.8 to 680 μg/ml in gall bladder bile. cefoperazone concentrations of the gall bladder wall ranged from 16.8 to 48.0 μg/g [3].

references

[1] matsubara n, minami s, muraoka t, et al. in vitro antibacterial activity of cefoperazone (t-1551), a new semisynthetic cephalosporin[j]. antimicrobial agents and chemotherapy, 1979, 16(6): 731-735.[2] baker c n, thornsberry c, jones r n. in vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (ly127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against neisseria gonorrhoeae and haemophilus influenzae, including beta-lactamase-producing strains[j]. antimicrobial agents and chemotherapy, 1980, 17(4): 757-761.[3] nakamura t, hashimoto i, sawada y, et al. cefoperazone concentrations in bile and gall bladder wall after intravenous administration[j]. antimicrobial agents and chemotherapy, 1980, 18(6): 980-982.

InChI:InChI=1/C25H27N9O8S2.Na/c1-3-32-8-9-33(21(39)20(32)38)24(42)27-15(12-4-6-14(35)7-5-12)18(36)26-16-19(37)34-17(23(40)41)13(10-43-22(16)34)11-44-25-28-29-30-31(25)2;/h4-7,15-16,22,35H,3,8-11H2,1-2H3,(H,26,36)(H,27,42)(H,40,41);/q;+1/p-1/t15-,16-,22-;/m1./s1

62893-20-3 Relevant articles

New adaptation diseases of cefoperazone medicinal preparation for treating endometritis and other gynecological genital tract infections

-

Paragraph 0108; 0012-0013; 0121-0126; 0143; 0144, (2020/08/22)

The invention discloses new adaptation d...

Cefoperazone sodium compound prepared by using fluid mechanics principle and preparation comprising cefoperazone sodium compound

-

Paragraph 0025; 0026; 0037; 0038; 0039-0044; 0054-0057, (2017/05/12)

The invention discloses a cefoperazone s...

Cefoperazone sodium compound and sulbactam sodium compound prepared with strong-field coupling crystallization technology as well as prepared composition

-

Paragraph 0042-0045; 0046; 0047; 0048-0051; 0071-0075, (2017/06/21)

The invention discloses a cefoperazone s...

A NEW CRYSTAL FORM OF CEFOPERAZONE SODIUM

-

Page/Page column 6; 7, (2014/02/15)

The present invention relates to a new c...

62893-20-3 Process route

cefoperazone
62893-19-0,68779-10-2

cefoperazone

Cefobis
62893-20-3

Cefobis

Conditions
Conditions Yield
With sodium hydrogencarbonate; In water; acetone; at 15 - 25 ℃; for 0.666667h; pH=6.5 - 6.6;
98.1%
With sodium isooctanoate; pyrographite; In acetone; at 25 ℃; pH=6.6; Reagent/catalyst; pH-value;
71.8%
With sodium carbonate; In water; ethyl acetate; at 25 ℃; pH=6.2; Temperature; Solvent; pH-value;
102.61 g
With sodium hydrogencarbonate; In ethanol; water; at 30 ℃; pH=6; Reagent/catalyst; Solvent; Temperature; pH-value;
453g
7-Aminocephalosporanic acid
957-68-6

7-Aminocephalosporanic acid

Cefobis
62893-20-3

Cefobis

Conditions
Conditions Yield
Multi-step reaction with 3 steps
1: pyridine; titanium tetrachloride; tetrabutoxytitanium / acetonitrile / 3 h / 5 - 30 °C
2: chloro-trimethyl-silane / N,N-dimethyl-formamide / 4 h / -25 - -20 °C
3: sodium isooctanoate; pyrographite / acetone / 25 °C / pH 6.6
With pyridine; tetrabutoxytitanium; chloro-trimethyl-silane; sodium isooctanoate; titanium tetrachloride; pyrographite; In N,N-dimethyl-formamide; acetone; acetonitrile;

62893-20-3 Upstream products

  • 62893-19-0
    62893-19-0

    cefoperazone

  • 957-68-6
    957-68-6

    7-Aminocephalosporanic acid

62893-20-3 Downstream products

  • 1448807-93-9
    1448807-93-9

    C25H26N9O8S2(1-)*Fe(2+)*Cl(1-)

  • 1448808-06-7
    1448808-06-7

    C25H26N9O8S2(1-)*Cd(2+)*Cl(1-)

Leave Your Message

Relevant Products